Giovannoni G, et al. Treatment outcomes of daclizumab in patients at high risk of transitioning to secondary progressive multiple sclerosis in DECIDE. EAN 2107, O2113.
ECTRIMS 2015 video update Teunissen: Progressive MS - how do we meet the therapeutic challenge?
jun 2017